Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro

Catechins may influence both desirable and undesirable effects of many drugs. In this study, the in vitro effect of (+)-catechin, (-)-epicatechin, (-)-epigallocatechin, (-)-epicatechin gallate, and (-)-epigallocatechin gallate (EGCG) on the efficacy of anticancer drug doxorubicin (DOX) was studied i...

Full description

Saved in:
Bibliographic Details
Main Authors: Rudolfová Petra, Hanušová Veronika, Skálová Lenka, Bártíková Hana, Matoušková Petra, Boušová Iva
Format: Article
Language:English
Published: Sciendo 2014-06-01
Series:Acta Pharmaceutica
Subjects:
Online Access:http://www.degruyter.com/view/j/acph.2014.64.issue-2/acph-2014-0018/acph-2014-0018.xml?format=INT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832570799884599296
author Rudolfová Petra
Hanušová Veronika
Skálová Lenka
Bártíková Hana
Matoušková Petra
Boušová Iva
author_facet Rudolfová Petra
Hanušová Veronika
Skálová Lenka
Bártíková Hana
Matoušková Petra
Boušová Iva
author_sort Rudolfová Petra
collection DOAJ
description Catechins may influence both desirable and undesirable effects of many drugs. In this study, the in vitro effect of (+)-catechin, (-)-epicatechin, (-)-epigallocatechin, (-)-epicatechin gallate, and (-)-epigallocatechin gallate (EGCG) on the efficacy of anticancer drug doxorubicin (DOX) was studied in HCT-8 cancer cells. Rat hepatocytes were used to study the influence of EGCG on DOX hepatotoxicity. Cell proliferation and viability were studied by 3-[4,5-dimethylthiazol- 2-yl]-2,5-diphenyl tetrazolium bromide and neutral red uptake test assays. Formation of reactive oxygen species (ROS) was determined using the dichlorofluorescein assay. All of the studied catechins (1-25 μmol L-1) had no effect on the proliferation of intestinal cancer cells and did not affect the antiproliferative effect of DOX (1-8 μmol L-1) in these cells. Moreover, EGCG at 25 μmol L-1 increased the viability of isolated hepatocytes and significantly protected these cells against DOX-induced toxicity and ROS production. Consumption of EGCG during DOX therapy seems to be safe and beneficial, since EGCG does not decrease DOX anticancer efficacy and could ameliorate DOX hepatotoxicity
format Article
id doaj-art-c0330aaba409440b97fe2d071fae53bb
institution Kabale University
issn 1330-0075
1846-9558
language English
publishDate 2014-06-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-c0330aaba409440b97fe2d071fae53bb2025-02-02T14:17:10ZengSciendoActa Pharmaceutica1330-00751846-95582014-06-0164219920910.2478/acph-2014-0018acph-2014-0018Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitroRudolfová Petra0Hanušová Veronika1Skálová Lenka2Bártíková Hana3Matoušková Petra4Boušová Iva5Department of Biochemical Sciences Charles University in Prague, Faculty of Pharmacy in Hradec Králové CZ-500 05 Hradec Králové Czech RepublicDepartment of Biochemical Sciences Charles University in Prague, Faculty of Pharmacy in Hradec Králové CZ-500 05 Hradec Králové Czech RepublicDepartment of Biochemical Sciences Charles University in Prague, Faculty of Pharmacy in Hradec Králové CZ-500 05 Hradec Králové Czech RepublicDepartment of Biochemical Sciences Charles University in Prague, Faculty of Pharmacy in Hradec Králové CZ-500 05 Hradec Králové Czech RepublicDepartment of Biochemical Sciences Charles University in Prague, Faculty of Pharmacy in Hradec Králové CZ-500 05 Hradec Králové Czech RepublicDepartment of Biochemical Sciences Charles University in Prague, Faculty of Pharmacy in Hradec Králové CZ-500 05 Hradec Králové Czech RepublicCatechins may influence both desirable and undesirable effects of many drugs. In this study, the in vitro effect of (+)-catechin, (-)-epicatechin, (-)-epigallocatechin, (-)-epicatechin gallate, and (-)-epigallocatechin gallate (EGCG) on the efficacy of anticancer drug doxorubicin (DOX) was studied in HCT-8 cancer cells. Rat hepatocytes were used to study the influence of EGCG on DOX hepatotoxicity. Cell proliferation and viability were studied by 3-[4,5-dimethylthiazol- 2-yl]-2,5-diphenyl tetrazolium bromide and neutral red uptake test assays. Formation of reactive oxygen species (ROS) was determined using the dichlorofluorescein assay. All of the studied catechins (1-25 μmol L-1) had no effect on the proliferation of intestinal cancer cells and did not affect the antiproliferative effect of DOX (1-8 μmol L-1) in these cells. Moreover, EGCG at 25 μmol L-1 increased the viability of isolated hepatocytes and significantly protected these cells against DOX-induced toxicity and ROS production. Consumption of EGCG during DOX therapy seems to be safe and beneficial, since EGCG does not decrease DOX anticancer efficacy and could ameliorate DOX hepatotoxicityhttp://www.degruyter.com/view/j/acph.2014.64.issue-2/acph-2014-0018/acph-2014-0018.xml?format=INTepigallocatechin gallatechemopreventionHCT- -8 cellshepatocytesdoxorubicin
spellingShingle Rudolfová Petra
Hanušová Veronika
Skálová Lenka
Bártíková Hana
Matoušková Petra
Boušová Iva
Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
Acta Pharmaceutica
epigallocatechin gallate
chemoprevention
HCT- -8 cells
hepatocytes
doxorubicin
title Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
title_full Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
title_fullStr Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
title_full_unstemmed Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
title_short Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
title_sort effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
topic epigallocatechin gallate
chemoprevention
HCT- -8 cells
hepatocytes
doxorubicin
url http://www.degruyter.com/view/j/acph.2014.64.issue-2/acph-2014-0018/acph-2014-0018.xml?format=INT
work_keys_str_mv AT rudolfovapetra effectofselectedcatechinsondoxorubicinantiproliferativeefficacyandhepatotoxicityinvitro
AT hanusovaveronika effectofselectedcatechinsondoxorubicinantiproliferativeefficacyandhepatotoxicityinvitro
AT skalovalenka effectofselectedcatechinsondoxorubicinantiproliferativeefficacyandhepatotoxicityinvitro
AT bartikovahana effectofselectedcatechinsondoxorubicinantiproliferativeefficacyandhepatotoxicityinvitro
AT matouskovapetra effectofselectedcatechinsondoxorubicinantiproliferativeefficacyandhepatotoxicityinvitro
AT bousovaiva effectofselectedcatechinsondoxorubicinantiproliferativeefficacyandhepatotoxicityinvitro